Propionic Acid

Propionic Acid

SCHEMBL4155591

CCC(=O)O.Cc1ccc(S(=O)(=O)Nc2ccc3[nH]c(=O)c4[nH]ccc4c3c2)cc1

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 5/20 0.50
ESR1 P03372 1/20 0.48
CYP19A1 P11511 1/20 0.48
BRAF P15056 1/20 0.47
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
JAK1 P23458 1/20 0.44
ALDH1A1 P00352 2/20 0.43
PKM P14618 2/20 0.43
HIF1A Q16665 1/20 0.43
MAPT P10636 4/20 0.42
TP53 P04637 3/20 0.42
LMNA P02545 1/20 0.42
HTR6 P50406 1/20 0.42
POLB P06746 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4157631 0.94 BRAF (0.54) ESR1CYP19A1BRAFMEN1KMT2A
Propionic Acid SCHEMBL4158106 0.92 BRD4 (0.60) BRD4HTR6
Propionic Acid SCHEMBL4169897 0.91 BRD4 (0.59) BRD4ESR1PKMHIF1AMAPT
Propionic Acid SCHEMBL4159957 0.91 BRD4 (0.49) BRD4ESR1MEN1KMT2AJAK1
Propionic Acid SCHEMBL4155599 0.91 BRD4 (0.49) BRD4ESR1BRAFMEN1KMT2A
Propionic Acid SCHEMBL4162543 0.90 MEN1 (0.54) BRD4MEN1KMT2APKMMAPT
Propionic Acid SCHEMBL4162384 0.90 MAPT (0.49) BRD4MEN1KMT2AALDH1A1MAPT
Propionic Acid SCHEMBL4164250 0.90 BRD4 (0.62) BRD4ESR1MEN1KMT2AALDH1A1
Propionic Acid SCHEMBL4162506 0.90 BRD4 (0.50) BRD4BRAFALDH1A1PKMHIF1A
Propionic Acid SCHEMBL4162655 0.90 BRD4 (0.62) BRD4MEN1KMT2AALDH1A1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US claimed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US claimed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 BRD4 545/4885ESR1 2823/4885CYP19A1 2824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.